Protection against Omicron BA.1/BA.2 severe disease 0–7 months after BNT162b2 booster

Following evidence of waning immunity against both infection and severe disease after 2 doses of the BNT162b2 vaccine, Israel began administering a 3rd BNT162b2 dose (booster) in July 2021. Recent studies showed that the 3rd dose provides a much lower protection against infection with the Omicron va...

Descripción completa

Detalles Bibliográficos
Autores principales: Amir, Ofra, Goldberg, Yair, Mandel, Micha, Bar-On, Yinon M., Bodenheimer, Omri, Freedman, Laurence, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit, Milo, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035472/
https://www.ncbi.nlm.nih.gov/pubmed/36959496
http://dx.doi.org/10.1038/s42003-023-04669-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035472/
https://www.ncbi.nlm.nih.gov/pubmed/36959496
http://dx.doi.org/10.1038/s42003-023-04669-6

Ejemplares similares